AzTrials
AzTrials

ShoulderPhase 4NCT00702416

Ultrasound Guidance for Interscalene Brachial Plexus Block

A Phase 4 study testing Ultrasound-guided continuous interscalene brachial plexus block, Continuous interscalene brachial plexus block using electrical nerve stimulation and Ropivacaine in people with Shoulder and Orthopedic Surgery, run by University of Parma at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study has been designed to assess the possible advantages of using ultrasound imaging to block the brachial plexus (i.e., nerves of the upper limb) in patients undergoing shoulder surgery. The ultrasound technique will be compared with the current gold standard, electrical nerve stimulation. Read more about this study

Who is it for?
Ages 18 to 85 years
Conditions the study is for
Shoulder, Orthopedic Surgery, Nerve Block
What is being tested?
Ultrasound-guided continuous interscalene brachial plexus block, Continuous interscalene brachial plexus block using electrical nerve stimulation and Ropivacaine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteItaly
Study dates
May 2008to Nov 2009
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ASA Physical Status Class I-III
  • Elective surgery of the shoulder
  • Informed consent to regional anesthesia

Who cannot join

  • Inability to effectively communicate
  • Chronic opioid use
  • Absence of informed consent to participation to the study
  • Ipsilateral upper limb neurological deficits
  • Known allergy to study medications
  • Contraindications to continuous block placement

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • University Hospital / Azienda Ospedaliero-Universitaria

    Parma, PR, 43100

Other trials in Italy

About this study

Official title: Ultrasound Guidance or Electrical Nerve Stimulation for Interscalene Brachial Plexus Block: a Randomized, Controlled Trial

This study has been designed to assess the possible advantages of using ultrasound imaging to block the brachial plexus (i.e., nerves of the upper limb) in patients undergoing shoulder surgery.

The ultrasound technique will be compared with the current gold standard, electrical nerve stimulation.

The aim of this study is to define which technique is better in terms of time to onset of anesthesia.

Read the detailed description

The study will compare real-time ultrasound (US) guidance and electrical nerve stimulation (ENS) in terms of onset time for interscalene brachial plexus anesthesia.

The main hypothesis is that direct visualization of neural structures under US guidance will grant better local anesthetic (LA) disposition around the roots of the plexus, thus improving onset times.

Perineural catheters will be used to maintain regional analgesia for 48 hours after surgery. We hypothesize that US guidance may also help physicians place perineural catheters more precisely, thus improving analgesia in the following hours to days.

Finally, we will investigate for possible differences in minor adverse events such as vascular puncture, pain during the anesthetic procedure.

Being tested
Ultrasound-guided continuous interscalene brachial plexus block, Continuous interscalene brachial plexus block using electrical nerve stimulation, Ropivacaine, Paracetamol, Morphine
Keywords
Analgesia, Patient-controlled, Anesthesia, Regional, Ultrasound, Postoperative Pain, Brachial Plexus
Medical subject headings
Agnosia, Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultrasound-guided continuous interscalene brachial plexus blockProcedure or surgery

    Also called Peripheral nerve block, Ultrasound, Regional anesthesia

    With patients in the supine position, a high-frequency (10-12 MHz) ultrasound transducer in a sterile sheath will be applied to explore the interscalene region and locate the brachial plexus. The transducer will be positioned so as to image the C5 and C6 roots in a single view. Visualization of the C7 root in the same scan will be sought, but will not be required.

    A 50-mm, 20 G needle will be advanced in-plane from the postero-lateral side of the transducer. Injection of the local anesthetic will be performed in small aliquots while repositioning of the needle in order to optimize spread of the injectate around the nerve roots.

    At the end of the injection, a catheter will be threaded through the needle. The catheter will be positioned to lie deep and close to the imaged nerve roots.

  • Continuous interscalene brachial plexus block using electrical nerve stimulationProcedure or surgery

    Also called Peripheral nerve block, Electrical nerve stimulation, Regional anesthesia

    With patients in the supine position, the head will be rotated to the contralateral side. The interscalene groove will be palpated.

    A 35-mm, 20 G needle will be inserted at the estimated C6 level (cricoid cartilage) with a 30-45° angle to the skin. The needle will be advanced along a line joining the insertion site to the axilla.

    An electrical nerve stimulator will be used at an initial intensity of 1.0 mA (frequency: 2 Hz, pulse width: 0.2 ms). A musculocutaneous or axillary-nerve mediated twitch will be sought

    Injection of the local anesthetic will start with a visible motor response at a current <0.5 mA. The catheter will be positioned to as to elicit a motor response at ≤0.4 mA.

  • RopivacaineDrug

    Also called Naropin, Local anesthetic, Amide local anesthetic

    Block induction [1% (wt/vol) solution]:

    20 ml (200 mg)

    Postoperative analgesia [0.2% (wt/vol) solution]:

    • Background infusion: 4 ml/h (8 mg/h)
    • Incremental on-demand dose: 2 ml (4 mg)
    • Lockout time: 15 min
  • ParacetamolDrug

    Also called Acetaminophen, Perfalgan, Analgesic

    1 g iv q8h

  • MorphineDrug

    Also called Opioid, Narcotic, Analgesic

    5 mg im prn q1h (in the postoperative period)

  • FentanylDrug

    Also called Opioid, Narcotic, Analgesic

    50 µg iv prn (in the intraoperative period)

  • General anesthesiaProcedure or surgery

    Also called Monitored anesthesia care

    Will be given in case of block failure and/or patient discomfort intractable with fentanyl during the procedure.

    The technique will be left at the discretion of the attending anesthesiologist. Monitored anesthesia care will also be acceptable; the block will be considered as failed in that case as well.

Study groups in NCT00702416
Study groupRoleWhat they receive
US GroupExperimentalIn this group, the continuous block will be performed under real-time ultrasound (US) guidance.
Receives: Procedure: Ultrasound-guided continuous interscalene brachial plexus block; Drug: Ropivacaine; Drug: Paracetamol; Drug: Morphine; Drug: Fentanyl; Procedure: General anesthesia
ENS GroupActive comparatorIn this group, the continuous block will be performed with an electrical nerve stimulation (ENS) technique.
Receives: Procedure: Continuous interscalene brachial plexus block using electrical nerve stimulation; Drug: Ropivacaine; Drug: Paracetamol; Drug: Morphine; Drug: Fentanyl; Procedure: General anesthesia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Onset time of brachial plexus anesthesia

    Measured: ≤30 min

Secondary outcomes (8)
  1. Successful brachial plexus anesthesia

    Measured: ≤30 min

  2. Additional analgesic requirements during surgery

    Measured: Duration of surgery

  3. Incidence of paresthesiae during the anesthetic procedure

    Measured: ≤30 min

  4. Incidence of blood aspiration during the anesthetic procedure

    Measured: ≤30 min

  5. Number of needle redirections for the performance of the block

    Measured: ≤30 min

  6. Pain during performance of the block

    Measured: ≤30 min

  7. Pain at rest and on movement (visual analog scale)

    Measured: q8h until 48 h after surgery

  8. Local anesthetic consumption on patient-controlled pump

    Measured: ≤48 h

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jun 2008 (estimated)
  2. Study startMay 2008
  3. Primary completionNov 2009
  4. Study completionNov 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00702416
Sponsor's protocol ID
ANEST-ORT-01
Status last verified
Nov 2009
First submitted
19 Jun 2008
Last updated
16 Nov 2009
Results posted
No
Data monitoring committee
No

Publications

  • Casati A, Fanelli G, Aldegheri G, Berti M, Colnaghi E, Cedrati V, Torri G. Interscalene brachial plexus anaesthesia with 0.5%, 0.75% or 1% ropivacaine: a double-blind comparison with 2% mepivacaine. Br J Anaesth. 1999 Dec;83(6):872-5. doi: 10.1093/bja/83.6.872.

    PubMed 10700785
  • Stevens MF, Werdehausen R, Golla E, Braun S, Hermanns H, Ilg A, Willers R, Lipfert P. Does interscalene catheter placement with stimulating catheters improve postoperative pain or functional outcome after shoulder surgery? A prospective, randomized and double-blinded trial. Anesth Analg. 2007 Feb;104(2):442-7. doi: 10.1213/01.ane.0000253513.15336.25.

    PubMed 17242107
  • Casati A, Borghi B, Fanelli G, Montone N, Rotini R, Fraschini G, Vinciguerra F, Torri G, Chelly J. Interscalene brachial plexus anesthesia and analgesia for open shoulder surgery: a randomized, double-blinded comparison between levobupivacaine and ropivacaine. Anesth Analg. 2003 Jan;96(1):253-9, table of contents. doi: 10.1097/00000539-200301000-00051.

    PubMed 12505962
  • Casati A, Danelli G, Baciarello M, Corradi M, Leone S, Di Cianni S, Fanelli G. A prospective, randomized comparison between ultrasound and nerve stimulation guidance for multiple injection axillary brachial plexus block. Anesthesiology. 2007 May;106(5):992-6. doi: 10.1097/01.anes.0000265159.55179.e1.

    PubMed 17457131

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Ultrasound-guided continuous interscalene brachial plexus block, Continuous interscalene brachial plexus block using electrical nerve stimulation and Ropivacaine in people with Shoulder and Orthopedic Surgery, run by University of Parma at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Nov 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Onset time of brachial plexus anesthesia (time frame: ≤30 min). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00702416, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Nov 2009.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in